Skip to main content
. 2022 Feb 10;10(2):418. doi: 10.3390/biomedicines10020418

Table 1.

Summary of major clinical trials.

TRIAL Inclusion Criteria Number of Patients Mean/Median
Age
Median NIHSS IV tPA Re
Perfusion
sICH mRS Less than 2 at 90 Days limitation Mortality
90 Days
MR CLEAN NIHSS > 2, occlusion of vessel imaging
500
I: 233
C:267
I:65.8
C65.7
I: 17
C: 18
I: 87.1
C:90.6
58.7 I 7.7
C6.4
I 32.6
C 19.1
No perfusion imaging.
Low reperfusion rate
I:18.9
C:18.4
At 30 days
ESCAPE NIHSS > 5, ASPECT > 6, collateral assessment, stent retriever in 84% 315
I 165
C150
I 71
C 70
I 16
C 17
I 72.7
C 78.7
72.4% I 3.6
C2.7
I 53
C29.3
No perfusion imaging I: 10.4 at 90 days
C 19%
EXTEND IA Age > 18 y
Collateral assesment, perfusion imaging
70
I 35
C 35
I 78.6
C 70.2
I 17
C 13
I 100
C 100
86% I 0
C 6
I 71
C 40
Small sample size I 9%
C 20%
SWIFT PRIME NIHSS 8–29
ASPECT > 6
Perfusion imaging
196
I 98
C 98
I 65
C 66.3
I 17
C 17
I 100
C 100
83% I 0
C 3
I 16
C 35
All patients received IVT I 9
C12
REVASCAT NIHSS > 6
ASPECT > 6
AGE 18–85 years
206
I 103
C 103
I 65.7
C 67.2
I 17
C 17
I 68
C 77
65.6% I 4.9
C1.9
I 43.7
C28.2
Low reperfusion rate I: 18.4%
C:15.5%
DAWN NIHSS > 10
Core and clinical mismatch
Up to 24 h
206
I 107
C 99
I 69.4
C 70.7
I 17
C 17
I 5
C 13
84% I 6
C 3
I 49
C 13
Severe stroke, Difference in baseline variables I 19
C 18
DIFFUSE 3 Perfusion with mismatch
6–16
182
I 92
C 90
I 70
C 71
I 16
C 16
I 11
C 9
76% I 7%
C 4%
I 45%
C 17%
Patient papulation is older. I 14%
C 26%